Jinhua Lan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jinhua Lan has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Chunbo Chen
Department of Critical Care Medicine, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), China
3 shared publications Fen Yao
Department of Critical Care Medicine The First Affiliated Hospital Shenzhen People's Hospital The Second Clinical Medical College of Jinan University Southern University of Science and Technology Shenzhen People's Republic of China
3 shared publicationsJingchun Chen
School of Biology and Biological Engineering South China University of Technology Guangzhou People's Republic of China
3 shared publicationsYifan Wang
Department of Critical Care Medicine The First Affiliated Hospital Shenzhen People's Hospital The Second Clinical Medical College of Jinan University Southern University of Science and Technology Shenzhen People's Republic of China
3 shared publicationsYirong Wang
Department of Critical Care Medicine The First Affiliated Hospital Shenzhen People's Hospital The Second Clinical Medical College of Jinan University Southern University of Science and Technology Shenzhen People's Republic of China
3 shared publicationsZheng Wu
School of Biology and Biological Engineering South China University of Technology Guangzhou People's Republic of China
3 shared publications
Latest Publications
- Open Access
- 1 February 2026
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 20, 1-13
A Multi-Center Study of Population Pharmacokinetics of Polymyxin B in Critically Ill Patients
To develop a population pharmacokinetics (PPK) model for polymyxin B (PB) in critically ill patients, and propose individualized dosing regimens. Methods: Blood samples were collected from intensive care unit (ICU) patients after the third or subsequent PB doses. The NONMEM software was used to construct a PPK model, with a focus on identifying key covariates influencing drug behavior. Patient-specific dosing strategies and probability of target attainment (PTA) were evaluated using Monte Carlo simulations. Results: A total of 56 ICU patients with 350 blood samples were included. A two-compartment model best described the data, with estimated glomerular filtration rate (eGFR) identified as a significant covariate on clearance (CL). The value of CL was 1.68 L/h. The estimated central compartment volume (V 1) was 14.3 L, the peripheral compartment volume (V 2) was 48.84 L, and the intercompartmental clearance (Q) was 4.67 L/h. The simulation results demonstrated a positive correlation between probability of target attainment (PTA) and maintenance dose (MD) at a fixed first dose (FD) for any given minimum inhibitory concentration (MIC). Conversely, a similar increase in PTA with higher FD was observed when MD was held constant. Furthermore, achieving therapeutic targets required larger dosing regimens in patients with better renal function. Conclusion: PB clearance is influenced by eGFR in critically ill patients. Higher MIC values or preserved renal function necessitate increased dosing. This study provides tailored dosing recommendations for ICU patients based on renal function and MIC.
- 1 February 2026
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 20, 1-13
Open AccessA Multi-Center Study of Population Pharmacokinetics of Polymyxin B in Critically Ill Patients
To develop a population pharmacokinetics (PPK) model for polymyxin B (PB) in critically ill patients, and propose individualized dosing regimens. Methods: Blood samples were collected from intensive care unit (ICU) patients after the third or subsequent PB doses. The NONMEM software was used to construct a PPK model, with a focus on identifying key covariates influencing drug behavior. Patient-specific dosing strategies and probability of target attainment (PTA) were evaluated using Monte Carlo simulations. Results: A total of 56 ICU patients with 350 blood samples were included. A two-compartment model best described the data, with estimated glomerular filtration rate (eGFR) identified as a significant covariate on clearance (CL). The value of CL was 1.68 L/h. The estimated central compartment volume (V 1) was 14.3 L, the peripheral compartment volume (V 2) was 48.84 L, and the intercompartmental clearance (Q) was 4.67 L/h. The simulation results demonstrated a positive correlation between probability of target attainment (PTA) and maintenance dose (MD) at a fixed first dose (FD) for any given minimum inhibitory concentration (MIC). Conversely, a similar increase in PTA with higher FD was observed when MD was held constant. Furthermore, achieving therapeutic targets required larger dosing regimens in patients with better renal function. Conclusion: PB clearance is influenced by eGFR in critically ill patients. Higher MIC values or preserved renal function necessitate increased dosing. This study provides tailored dosing recommendations for ICU patients based on renal function and MIC.
- Open Access
- 1 August 2023
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 17, 2259-2271
Optimal Teicoplanin Dosage Regimens in Critically Ill Patients: Population Pharmacokinetics and Dosing Simulations Based on Renal Function and Infection Type
Purpose: To develop a population pharmacokinetic model describing teicoplanin concentrations in patients hospitalized in intensive care unit (ICU) and to perform Monte Carlo simulations to provide detailed dosing regimens of teicoplanin. Methods: This single-center, prospective, observational study was conducted on 151 patients in ICU with 347 plasma samples. The population pharmacokinetics model was established and various covariates were evaluated. The probability of target attainment (PTA) of various proposal dosing regimens was calculated by Monte Carlo simulations. Results: The two-compartment model adequately described teicoplanin concentration-time data. The estimated glomerular filtration rate (eGFR) associated with systemic clearance (CL) was the only covariate included in the final model. The estimate of CL was 0.838 L/h, with the eGFR adjustment factor of 0.00823. The volume of the central compartment (Vc), inter-compartmental clearance (Q) and volumes of the peripheral compartments (Vp) were 14.4 L, 3.08 L/h and 51.6 L, respectively. The simulations revealed that the standard dosage regimen was only sufficient for the patients with severe renal dysfunction (eGFR ≤ 30 mL/min/1.73 m2) to attain target trough concentration (Cmin, PTA 52.8%). When eGFR > 30 mL/min/1.73 m2, increasing dose and the administration times of loading doses were the preferred options to achieve target Cmin based on the renal function and types of infection. Conclusion: The most commonly used standard dosage regimen was insufficient for all ICU patients. Our study provided detailed dosing regimens of teicoplanin stratified by eGFR and types of infection for ICU patients.
- 1 August 2023
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 17, 2259-2271
Open AccessOptimal Teicoplanin Dosage Regimens in Critically Ill Patients: Population Pharmacokinetics and Dosing Simulations Based on Renal Function and Infection Type
Purpose: To develop a population pharmacokinetic model describing teicoplanin concentrations in patients hospitalized in intensive care unit (ICU) and to perform Monte Carlo simulations to provide detailed dosing regimens of teicoplanin. Methods: This single-center, prospective, observational study was conducted on 151 patients in ICU with 347 plasma samples. The population pharmacokinetics model was established and various covariates were evaluated. The probability of target attainment (PTA) of various proposal dosing regimens was calculated by Monte Carlo simulations. Results: The two-compartment model adequately described teicoplanin concentration-time data. The estimated glomerular filtration rate (eGFR) associated with systemic clearance (CL) was the only covariate included in the final model. The estimate of CL was 0.838 L/h, with the eGFR adjustment factor of 0.00823. The volume of the central compartment (Vc), inter-compartmental clearance (Q) and volumes of the peripheral compartments (Vp) were 14.4 L, 3.08 L/h and 51.6 L, respectively. The simulations revealed that the standard dosage regimen was only sufficient for the patients with severe renal dysfunction (eGFR ≤ 30 mL/min/1.73 m2) to attain target trough concentration (Cmin, PTA 52.8%). When eGFR > 30 mL/min/1.73 m2, increasing dose and the administration times of loading doses were the preferred options to achieve target Cmin based on the renal function and types of infection. Conclusion: The most commonly used standard dosage regimen was insufficient for all ICU patients. Our study provided detailed dosing regimens of teicoplanin stratified by eGFR and types of infection for ICU patients.
- Open Access
- 25 January 2022
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 111 (6) , 1833-1842
Population Pharmacokinetics Analysis and Dosing Simulations Of Meropenem in Critically Ill Patients with Pulmonary Infection
- 25 January 2022
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 111 (6) , 1833-1842
Open AccessPopulation Pharmacokinetics Analysis and Dosing Simulations Of Meropenem in Critically Ill Patients with Pulmonary Infection